- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Ampio Pharmaceuticals Inc
+ Add to WatchlistAMPE:US
5.0800 USD 0.3900 8.32%As of 17:20:00 ET on 05/23/2013.
Snapshot for Ampio Pharmaceuticals Inc (AMPE)
| Open: | 4.7600 | Day's Range: | 4.7200 - 5.1000 | Volume: | 529,569 |
|---|---|---|---|---|---|
| Previous Close: | 4.6900 | 52wk Range: | 2.5500 - 6.2500 | 1-Yr Rtn: | +88.85% |
Key Statistics for AMPE
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.3600 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 188.40 |
| Shares Outstanding (M) | 37.09 |
| 30 Day Average Volume | 266,367 |
| Price/Book (mrq) | 8.1931 |
| Price/Sale (ttm) | 3,585.2310 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AMPE
Company Profile & Key Executives for AMPE
Ampio Pharmaceuticals, Inc. researches and develops drugs. The Company researches treatments for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The Company's product pipeline includes some new uses for previously approved drugs.
| Michael Macaluso JrChairman/CEO | Mark D McGregorCFO/Secretary |
| Josh DisbrowChief Operating Officer | Vaughan L CliftChief Regulatory Affairs Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AMPE News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page